MedPath
HSA Approval

DIFFERIN GEL 0.1%

SIN08957P

DIFFERIN GEL 0.1%

DIFFERIN GEL 0.1%

October 7, 1996

GALDERMA SINGAPORE PRIVATE LIMITED

GALDERMA SINGAPORE PRIVATE LIMITED

Regulatory Information

GALDERMA SINGAPORE PRIVATE LIMITED

GALDERMA SINGAPORE PRIVATE LIMITED

Therapeutic

Prescription Only

Formulation Information

GEL

**DOSAGE AND ADMINISTRATION** Differin Gel should be applied to the acne affected areas once a day before retiring and after washing. A thin film of the product should be applied avoiding the eyes and lips (see Warnings and Precautions – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Ensure that the affected areas are dry before application. With patients for whom it is necessary to reduce the frequency of application or to temporarily discontinue treatment, frequency of application may be restored or therapy resumed once it is judged that the patient can again tolerate the treatment. If patients use cosmetics, these should be non-comedogenic and non-astringent. The safety and effectiveness of Differin products have not been studied in children below 12 years of age.

TOPICAL

Medical Information

**INDICATIONS** Differin Gel is proposed for the cutaneous treatment of acne vulgaris where comedones, papules and pustules predominate. Acne of the face, chest or back is appropriate for treatment.

**CONTRA-INDICATIONS** Pregnancy (see section Pregnancy and Lactation – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Women planning a pregnancy. Hypersensitivity to the active substance or to any of the excipients.

D10AD03

adapalene

Manufacturer Information

GALDERMA SINGAPORE PRIVATE LIMITED

LABORATOIRES GALDERMA

Active Ingredients

ADAPALENE

0.1% w/w

Adapalene

Documents

Package Inserts

Differin Gel PI.pdf

Approved: October 29, 2020

Download
© Copyright 2025. All Rights Reserved by MedPath
DIFFERIN GEL 0.1% - HSA Approval | MedPath